Source comparison
Comparison: CJC-1295 & Ipamorelin Protocol Variations
Standard 40+ Protocol No DAC 100–200mcg Once daily (PM) 2 per week Age 40–60, metabolic recovery focus Optimal for maintaining pulsatile rhythm and avoiding receptor desensitisation High-Frequency Protocol 100mcg Twice daily (AM/PM) Aggressive recomposition re
This comparison does not assign a generated winner or score.
- Standard 40+ Protocol
- No DAC
- 100–200mcg
- Once daily (PM)
- 2 per week
- Age 40–60, metabolic recovery focus
- Optimal for maintaining pulsatile rhythm and avoiding receptor desensitisation
- High-Frequency Protocol
- 100mcg
- Twice daily (AM/PM)
- Aggressive recomposition research
- Higher receptor fatigue risk; requires stricter cycling
- DAC-Based Protocol
- With DAC
- 1–2x weekly
- None
- Age <35, infrequent dosing preference
- Creates chronic GH elevation; not recommended for 40+ cohorts
- Ipamorelin Solo
- 200–300mcg
- Budget-constrained or GHRH-sensitive individuals
- Weaker amplitude without GHRH synergy; 40–60% of combined effect
- CJC-1295 Solo
- 200mcg
- None needed
- Ghrelin receptor issues or Ipamorelin intolerance
- Extends pulse but doesn't initiate; suboptimal without ghrelin trigger